Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii

Abstract Background Tigecycline, with broad in vitro antibacterial activity, has been widely used off-label for nosocomial pneumonia caused by multi-drug resistant Acinetobacter baumannii (MDRAB). However, many concerns have been raised about the efficacy of tigecycline treatment as the inconsistent...

Descrición completa

Detalles Bibliográficos

Principais autores:	Yangang Zhou, Xumin Chen, Ping Xu, Yan Zhu, Kuangguo Wang, Daxiong Xiang, Feng Wang, Hoan Linh Banh
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2019-04-01
Series:	BMC Pharmacology and Toxicology
Assuntos:	Tigecycline Multi-drug resistance Acinetobacter baumannii Hospital-acquired pneumonia
Acceso en liña:	http://link.springer.com/article/10.1186/s40360-019-0300-3
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!